Anticorps Recombinant de lapin anti-Phospho-SMAD2 (Ser465/467)/SMAD3 (Ser423/425)

Phospho-SMAD2 (Ser465/467)/SMAD3 (Ser423/425) Recombinant Antibody for WB, IF/ICC, FC (Intra), ELISA, ChIP-qPCR

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, IF/ICC, FC (Intra), ELISA, ChIP-qPCR

Conjugaison

Non conjugué

CloneNo.

240826D11

N° de cat : 80427-2-PBS

Synonymes

P SMAD2, p SMAD2 (Ser465/467), P SMAD2 (Ser465/467)/SMAD3 (Ser423/425), P SMAD2 Ser465/467 /SMAD3 Ser423/425, p SMAD2/SMAD3



Informations sur le produit

80427-2-PBS cible Phospho-SMAD2 (Ser465/467)/SMAD3 (Ser423/425) dans les applications de WB, IF/ICC, FC (Intra), ELISA, ChIP-qPCR et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène Peptide
Nom complet SMAD family member 2
Masse moléculaire calculée 467 aa, 52 kDa
Poids moléculaire observé60 kDa
Numéro d’acquisition GenBankBC014840
Symbole du gène SMAD2
Identification du gène (NCBI) 4087
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

SMAD2, also named as MADH2 and MADR2, belongs to the dwarfin/SMAD family, contains 1 MH1 (MAD homology 1) domain and 1 MH2 (MAD homology 2) domain. SMAD2 is a receptor-regulated SMAD(R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta and activin type 1 receptor kinases. This protein may act as a tumor suppressor in colorectal carcinoma. It is phosphorylated on one or several of Thr-220, Ser-245, Ser-250, and Ser-255. In response to TGF-beta, It is phosphorylated on Ser-465/467 by TGF-beta and activin type 1 receptor kinases, and then able to interact with SMURF2, recruiting other proteins, such as SNON, for degradation. In response to decorin, the naturally occurring inhibitor of TGF-beta signaling, it is phosphorylated on Ser-240 by CaMK2. It is phosphorylated by MAPK3 upon EGF stimulation; which increases transcriptional activity and stability, and is blocked by calmodulin. In response to TGF-beta, it is ubiquitinated by NEDD4L, which promotes its degradation. In response to TGF-beta signaling, it is acetylated on Lys-19 by coactivators, which increases transcriptional activity. The molecular weight of unphosphorylated forms of Smad2 is 52 kDa and phosphorylated forms of Smad2 is 58 kDa. (PMID: 9006934)

{{ptg:RelatedPrimaryAntibodies}}